Selected research
Industry Growth & Trends
Global Non Narcotic Analgesics Industry Growth and Trends Forecast to 2032
Market perspective
The global Non Narcotic Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non Narcotic Analgesics include Endo Pharmaceuticals, Reckitt Benckiser, GlaxoSmithKline PLC, Pfizer, Novartis AG and Sanofi S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Non Narcotic Analgesics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Non Narcotic Analgesics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non Narcotic Analgesics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non Narcotic Analgesics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Non Narcotic Analgesics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Non Narcotic Analgesics Market by Company
Endo Pharmaceuticals
Reckitt Benckiser
GlaxoSmithKline PLC
Pfizer
Novartis AG
Sanofi S.A.
Non Narcotic Analgesics Segment by Type
Non Steroid Antiinflammatory Drug
Steroid Antiinflammatory Drug
Non Narcotic Analgesics Segment by Application
Hospital
Medical Center
Others
Non Narcotic Analgesics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Narcotic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non Narcotic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Narcotic Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non Narcotic Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non Narcotic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non Steroid Antiinflammatory Drug
- Steroid Antiinflammatory Drug
Applications
- Hospital
- Medical Center
- Others
Companies covered
- Endo Pharmaceuticals
- Reckitt Benckiser
- GlaxoSmithKline PLC
- Pfizer
- Novartis AG
- Sanofi S.A.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Non Narcotic Analgesics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Non Narcotic Analgesics Sales Estimates and Forecasts (2021-2032)
- 1.3 Non Narcotic Analgesics Market by Type
- 1.3.1 Non Steroid Antiinflammatory Drug
- 1.3.2 Steroid Antiinflammatory Drug
- 1.4 Global Non Narcotic Analgesics Market Size by Type
- 1.4.1 Global Non Narcotic Analgesics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Non Narcotic Analgesics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Non Narcotic Analgesics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Non Narcotic Analgesics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Non Narcotic Analgesics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Non Narcotic Analgesics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Non Narcotic Analgesics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Non Narcotic Analgesics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Non Narcotic Analgesics Industry Trends
- 2.2 Non Narcotic Analgesics Industry Drivers
- 2.3 Non Narcotic Analgesics Industry Opportunities and Challenges
- 2.4 Non Narcotic Analgesics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Non Narcotic Analgesics Revenue (2021-2026)
- 3.2 Global Top Players by Non Narcotic Analgesics Sales (2021-2026)
- 3.3 Global Top Players by Non Narcotic Analgesics Price (2021-2026)
- 3.4 Global Non Narcotic Analgesics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non Narcotic Analgesics Major Company Production Sites & Headquarters
- 3.6 Global Non Narcotic Analgesics Company, Product Type & Application
- 3.7 Global Non Narcotic Analgesics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non Narcotic Analgesics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non Narcotic Analgesics Players Market Share by Revenue in 2025
- 3.8.3 2025 Non Narcotic Analgesics Tier 1, Tier 2, and Tier 3
4 Non Narcotic Analgesics Regional Status and Outlook
- 4.1 Global Non Narcotic Analgesics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Non Narcotic Analgesics Historic Market Size by Region
- 4.2.1 Global Non Narcotic Analgesics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Non Narcotic Analgesics Sales in Value by Region (2021-2026)
- 4.2.3 Global Non Narcotic Analgesics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Non Narcotic Analgesics Forecasted Market Size by Region
- 4.3.1 Global Non Narcotic Analgesics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Non Narcotic Analgesics Sales in Value by Region (2027-2032)
- 4.3.3 Global Non Narcotic Analgesics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non Narcotic Analgesics by Application
- 5.1 Non Narcotic Analgesics Market by Application
- 5.1.1 Hospital
- 5.1.2 Medical Center
- 5.1.3 Others
- 5.2 Global Non Narcotic Analgesics Market Size by Application
- 5.2.1 Global Non Narcotic Analgesics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Non Narcotic Analgesics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Non Narcotic Analgesics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Non Narcotic Analgesics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Non Narcotic Analgesics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Non Narcotic Analgesics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Non Narcotic Analgesics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Non Narcotic Analgesics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Endo Pharmaceuticals
- 6.1.1 Endo Pharmaceuticals Company Information
- 6.1.2 Endo Pharmaceuticals Business Overview
- 6.1.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolio
- 6.1.5 Endo Pharmaceuticals Recent Developments
- 6.2 Reckitt Benckiser
- 6.2.1 Reckitt Benckiser Company Information
- 6.2.2 Reckitt Benckiser Business Overview
- 6.2.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Reckitt Benckiser Non Narcotic Analgesics Product Portfolio
- 6.2.5 Reckitt Benckiser Recent Developments
- 6.3 GlaxoSmithKline PLC
- 6.3.1 GlaxoSmithKline PLC Company Information
- 6.3.2 GlaxoSmithKline PLC Business Overview
- 6.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolio
- 6.3.5 GlaxoSmithKline PLC Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Non Narcotic Analgesics Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Novartis AG
- 6.5.1 Novartis AG Company Information
- 6.5.2 Novartis AG Business Overview
- 6.5.3 Novartis AG Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Novartis AG Non Narcotic Analgesics Product Portfolio
- 6.5.5 Novartis AG Recent Developments
- 6.6 Sanofi S.A.
- 6.6.1 Sanofi S.A. Company Information
- 6.6.2 Sanofi S.A. Business Overview
- 6.6.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sanofi S.A. Non Narcotic Analgesics Product Portfolio
- 6.6.5 Sanofi S.A. Recent Developments
7 North America by Country
- 7.1 North America Non Narcotic Analgesics Sales by Country
- 7.1.1 North America Non Narcotic Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Non Narcotic Analgesics Sales by Country (2021-2026)
- 7.1.3 North America Non Narcotic Analgesics Sales Forecast by Country (2027-2032)
- 7.2 North America Non Narcotic Analgesics Market Size by Country
- 7.2.1 North America Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Non Narcotic Analgesics Market Size by Country (2021-2026)
- 7.2.3 North America Non Narcotic Analgesics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Non Narcotic Analgesics Sales by Country
- 8.1.1 Europe Non Narcotic Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Non Narcotic Analgesics Sales by Country (2021-2026)
- 8.1.3 Europe Non Narcotic Analgesics Sales Forecast by Country (2027-2032)
- 8.2 Europe Non Narcotic Analgesics Market Size by Country
- 8.2.1 Europe Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Non Narcotic Analgesics Market Size by Country (2021-2026)
- 8.2.3 Europe Non Narcotic Analgesics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Non Narcotic Analgesics Sales by Country
- 9.1.1 Asia-Pacific Non Narcotic Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Non Narcotic Analgesics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Non Narcotic Analgesics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Non Narcotic Analgesics Market Size by Country
- 9.2.1 Asia-Pacific Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Non Narcotic Analgesics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Non Narcotic Analgesics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Non Narcotic Analgesics Sales by Country
- 10.1.1 South America Non Narcotic Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Non Narcotic Analgesics Sales by Country (2021-2026)
- 10.1.3 South America Non Narcotic Analgesics Sales Forecast by Country (2027-2032)
- 10.2 South America Non Narcotic Analgesics Market Size by Country
- 10.2.1 South America Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Non Narcotic Analgesics Market Size by Country (2021-2026)
- 10.2.3 South America Non Narcotic Analgesics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Non Narcotic Analgesics Sales by Country
- 11.1.1 Middle East and Africa Non Narcotic Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Non Narcotic Analgesics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Non Narcotic Analgesics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Non Narcotic Analgesics Market Size by Country
- 11.2.1 Middle East and Africa Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Non Narcotic Analgesics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Non Narcotic Analgesics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Non Narcotic Analgesics Value Chain Analysis
- 12.1.1 Non Narcotic Analgesics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Non Narcotic Analgesics Production Mode & Process
- 12.2 Non Narcotic Analgesics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Non Narcotic Analgesics Distributors
- 12.2.3 Non Narcotic Analgesics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst